Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy.
Masao WatanabeYuji NakamotoTakayoshi IshimoriTsuneo SagaAki KidoJunzo HamanishiYasuyo HamanakaKaori TogashiPublished in: Annals of nuclear medicine (2019)
The reduction rate of FDG PET-based quantitative values and visual analysis after NAC demonstrated prognostic potential, especially in PFS.